Search Within

Heiko Schoder

  1. "Lymphoma"
Formats
  1. Journal Article (63)
  2. Meeting Abstract (61)
  3. Research Letter (4)
Groups
  1. Center for Hematologic Malignancies (128)
  2. Department of Medicine (128)
  3. Hematologic Malignancies, Division of (128)
  4. Lymphoma (128)
  5. Molecular Imaging and Therapy Service (128)
  6. Radiology, Department of (128)

More Groups

People
  1. Andrew Zelenetz (66)
  2. Alison Moskowitz (59)
  3. David Straus (56)
  4. Ariela Noy (55)
  5. Maria Palomba (53)
  6. Paul Hamlin (51)

More People

Years
  1. 2025 (5)
  2. 2024 (9)
  3. 2023 (15)
  4. 2022 (7)
  5. 2021 (11)
  6. 2020 (9)

More Years

Publications
  1. Blood (49)
  2. Journal of Clinical Oncology (14)
  3. Hematological Oncology (10)
  4. Blood Advances (6)
  5. Leukemia and Lymphoma (5)
  6. Annals of Oncology (4)

More Publications

Publishers
  1. American Society of Hematology (55)
  2. American Society of Clinical Oncology (14)
  3. Wiley Blackwell (12)
  4. Nature Publishing Group (6)
  5. Taylor & Francis Group (5)
  6. Ferrata Storti Foundation (4)

More Publishers

Results (128)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adnexal mass secondary to extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with associated amyloid deposition
    Journal Article

    Mehta, N.; Schòˆder, H.; Chiu, A.; Schoolmeester, J. K.; Portlock, C.
    BMJ Case Reports (2014)

    Fulltext@MSK | Save
  • Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Yahalom, J.; Schoder, H.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; Hamilton, A.; Hamlin, P.; Horwitz, S. M.; Jacob, A. G.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • FDG-PET adapted sequential therapy with brentuximab vedotin and augmented ICE followed by autologous stem cell transplant for relapsed and refractory Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A.; Schoder, H.; Gerecitano, J. F.; Hamlin, P.; Horwitz, S. M.; Matasar, M. J.; Keskinyan, V. S.; McCall, S.; Noy, A.; Palomba, M. L.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • The impact of systemic chemotherapy on testicular FDG activity in young men with Hodgkin's lymphoma
    Journal Article

    Burger, I. A.; Vargas, H. A.; Goldman, D. A.; Gonen, M.; Kumar, A.; Zelenetz, A. D.; Schòˆder, H.; Hricak, H.
    European Journal of Nuclear Medicine and Molecular Imaging (2013)

    Fulltext@MSK | Save
  • 18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphoma
    Journal Article

    Casulo, C.; Schoder, H.; Feeney, J.; Lim, R.; Maragulia, J.; Zelenetz, A. D.; Horwitz, S.
    Leukemia and Lymphoma (2013)

    Fulltext@MSK | Save
  • ABVD alone and a PET scan complete remission negates the need for radiologic surveillance in early-stage, nonbulky Hodgkin lymphoma
    Journal Article

    Hartridge-Lambert, S. K.; Schoder, H.; Lim, R. C.; Maragulia, J. C.; Portlock, C. S.
    Cancer (2013)

    Fulltext@MSK | Save
  • Evaluation of dual tracer (FLT and FDG) PET imaging as part of risk-adapted therapy for patients with advanced stage diffuse large B cell lymphoma (DLBCL)
    Meeting Abstract

    Moskowitz, C. H.; Schoder, H.; Hamlin, P.; Maragulia, J. C.; Walkley, J.; Zelenetz, A. D.
    Blood (2012)

    Fulltext@MSK | Save
  • Interim [18F]fluorodeoxyglucose positron emission tomography imaging in stage III non-bulky Hodgkin lymphoma: Would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?
    Journal Article

    Kostakoglu, L.; Schoder, H.; Johnson, J. L.; Hall, N. C.; Schwartz, L. H.; Straus, D. J.; LaCasce, A. S.; Jung, S. H.; Bartlett, N. L.; Canellos, G. P.; more...
    Leukemia and Lymphoma (2012)

    Fulltext@MSK | Save
  • Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma
    Journal Article

    Leonard, J. P.; LaCasce, A. S.; Smith, M. R.; Noy, A.; Chirieac, L. R.; Rodig, S. J.; Yu, J. Q.; Vallabhajosula, S.; Schoder, H.; English, P.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma
    Journal Article

    Moskowitz, C. H.; Matasar, M. J.; Zelenetz, A. D.; Nimer, S. D.; Gerecitano, J.; Hamlin, P.; Horwitz, S.; Moskowitz, A. J.; Noy, A.; Palomba, L.; more...
    Blood (2012)

    Fulltext@MSK | Save